Identification and Characterization of FAM124B as a Novel Component of a CHD7 and CHD8 Containing Complex

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Batsukh, Tserendulam ^a   Schulz, Yvonne ^a   Wolf, Stephan ^a   Rabe, Tamara I ^b   Oellerich, Thomas ^b,c   Urlaub, Henning ^a,b   Schaefer, Inga Marie ^a   Pauli, Silke ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMODOMAIN HELICASE DNA BINDING PROTEIN 7; CHROMODOMAIN HELICASE DNA BINDING PROTEIN 8; DNA BINDING PROTEIN; FAMILY WITH SEQUENCE SIMILARITY 124B PROTEIN; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; ISOTOPE LABELING; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SYNDROME CHARGE; WESTERN BLOTTING;

ANIMALS; CARRIER PROTEINS; CENTRAL NERVOUS SYSTEM; CHARGE SYNDROME; CLONING, MOLECULAR; DNA HELICASES; DNA-BINDING PROTEINS; GENE EXPRESSION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HELA CELLS; HUMANS; MICE; MULTIPROTEIN COMPLEXES; NUCLEAR PROTEINS; ORGAN SPECIFICITY; PROTEIN BINDING; PROTEIN TRANSPORT; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

MURINAE;

EID: 84871374136     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052640     Document Type: Article

References (33)

1. Vissers LE, van Ravenswaaij CM, Admiraal R, Hurst JA, de Vries BB, et al. (2004) Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat Genet 36: 955-957.
2. Aramaki M, Udaka T, Kosaki R, Makita Y, Okamoto N, et al. (2006) Phenotypic spectrum of CHARGE syndrome with CHD7 mutations. J Pediatr 148: 410-414.
3. Jongmans MC, Admiraal RJ, van der Donk KP, Vissers LE, Baas AF, et al. (2006) CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene. J Med Genet 43: 306-314.
4. Lalani SR, Safiullah AM, Fernbach SD, Harutyunyan KG, Thaller C, et al. (2006) Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation. Am J Hum Genet 78: 303-314.
5. Sanlaville D, Etchevers HC, Gonzales M, Martinovic J, Clement-Ziza M, et al. (2006) Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development. J Med Genet 43: 211-217.
6. Wincent J, Holmberg E, Stromland K, Soller M, Mirzaei L, et al. (2008) CHD7 mutation spectrum in 28 Swedish patients diagnosed with CHARGE syndrome. Clin Genet 74: 31-38.
7. Janssen N, Bergman JE, Swertz MA, Tranebjaerg L, Lodahl M, et al. (2012) Mutation update on the CHD7 gene involved in CHARGE syndrome. Hum Mutat 33: 1149-1160.
8. Takada I, Mihara M, Suzawa M, Ohtake F, Kobayashi S, et al. (2007) A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation. Nat Cell Biol 9: 1273-1285.
9. Schnetz MP, Bartels CF, Shastri K, Balasubramanian D, Zentner GE, et al. (2009) Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns. Genome Res 19: 590-601.
10. Bajpai R, Chen DA, Rada-Iglesias A, Zhang J, Xiong Y, et al. (2010) CHD7 cooperates with PBAF to control multipotent neural crest formation. Nature 463: 958-962.
11. Batsukh T, Pieper L, Koszucka AM, von Velsen N, Hoyer-Fender S, et al. (2010) CHD8 interacts with CHD7, a protein which is mutated in CHARGE syndrome. Hum Mol Genet 19: 2858-2866.
12. Schnetz MP, Handoko L, Akhtar-Zaidi B, Bartels CF, Pereira CF, et al. (2010) CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression. PLoS Genet 6: e1001023.
13. Zentner GE, Hurd EA, Schnetz MP, Handoko L, Wang C, et al. (2010) CHD7 functions in the nucleolus as a positive regulator of ribosomal RNA biogenesis. Hum Mol Genet 19: 3491-3501.
14. Ho L, Crabtree GR, (2010) Chromatin remodelling during development. Nature 463: 474-484.
15. Srinivasan S, Dorighi KM, Tamkun JW, (2008) Drosophila Kismet regulates histone H3 lysine 27 methylation and early elongation by RNA polymerase II. PLoS Genet 4: e1000217.
16. Rodriguez-Paredes M, Ceballos-Chavez M, Esteller M, Garcia-Dominguez M, Reyes JC, (2009) The chromatin remodeling factor CHD8 interacts with elongating RNA polymerase II and controls expression of the cyclin E2 gene. Nucleic Acids Res 37: 2449-2460.
17. Thompson BA, Tremblay V, Lin G, Bochar DA, (2008) CHD8 is an ATP-dependent chromatin remodeling factor that regulates beta-catenin target genes. Mol Cell Biol 28: 3894-3904.
18. Yokoyama A, Cleary ML, (2008) Menin critically links MLL proteins with LEDGF on cancer-associated target genes. Cancer Cell 14: 36-46.
19. Zahir F, Firth HV, Baross A, Delaney AD, Eydoux P, et al. (2007) Novel deletions of 14q11.2 associated with developmental delay, cognitive impairment and similar minor anomalies in three children. J Med Genet 44: 556-561.
20. Neale BM, Kou Y, Liu L, Ma'ayan A, Samocha KE, et al. (2012) Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485: 242-245.
21. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, et al. (2012) Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485: 246-250.
22. Talkowski ME, Rosenfeld JA, Blumenthal I, Pillalamarri V, Chiang C, et al. (2012) Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell 149: 525-537.
23. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, et al. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1: 376-386.
24. Oellerich T, Bremes V, Neumann K, Bohnenberger H, Dittmann K, et al. (2011) The B-cell antigen receptor signals through a preformed transducer module of SLP65 and CIN85. EMBO J 30: 3620-3634.
25. Betancur C, (2011) Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res 1380: 42-77.
26. Ishihara K, Oshimura M, Nakao M, (2006) CTCF-dependent chromatin insulator is linked to epigenetic remodeling. Mol Cell 23: 733-742.
27. Layman WS, McEwen DP, Beyer LA, Lalani SR, Fernbach SD, et al. (2009) Defects in neural stem cell proliferation and olfaction in Chd7 deficient mice indicate a mechanism for hyposmia in human CHARGE syndrome. Hum Mol Genet 18: 1909-1923.
28. Bosman EA, Penn AC, Ambrose JC, Kettleborough R, Stemple DL, et al. (2005) Multiple mutations in mouse Chd7 provide models for CHARGE syndrome. Hum Mol Genet 14: 3463-3476.
29. Hurd EA, Capers PL, Blauwkamp MN, Adams ME, Raphael Y, et al. (2007) Loss of Chd7 function in gene-trapped reporter mice is embryonic lethal and associated with severe defects in multiple developing tissues. Mamm Genome 18: 94-104.
30. Bergman JE, Bosman EA, van Ravenswaaij-Arts CM, Steel KP, (2010) Study of smell and reproductive organs in a mouse model for CHARGE syndrome. Eur J Hum Genet 18: 171-177.
31. Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M, (2006) In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 1: 2856-2860.
32. Nikolov M, Stutzer A, Mosch K, Krasauskas A, Soeroes S, et al. (2011) Chromatin affinity purification and quantitative mass spectrometry defining the interactome of histone modification patterns. Mol Cell Proteomics 10: M110 005371.
33. Moorman AF, Houweling AC, de Boer PA, Christoffels VM, (2001) Sensitive nonradioactive detection of mRNA in tissue sections: novel application of the whole-mount in situ hybridization protocol. J Histochem Cytochem 49: 1-8.